"GenTok Meets Samsung Health to Deliver Ultra-Personalized Health Solutions"
November 18, 2024 – Macrogen, a global digital healthcare leader, announced today that it has signed a service supply agreement with Samsung Electronics. This milestone follows a Memorandum of Understanding (MOU) for collaborative R&D on DNA testing-healthcare services signed in July. As part of this agreement, Macrogen’s genetic and microbiome-d digital healthcare platform, ‘Gentok,’ will be integrated into the Samsung Health app. This integration will enable Samsung Health users to access personalized health solutions tailored to their lifestyle logs and genetic data.
The launch of the Gentok, customized for Samsung Health, is slated for the first half of next year, with Gentok positioned prominently within the Samsung Health app. The service aims to provide personalized insights that extend beyond innate traits and lifestyle log-d tracker recommendations to deliver actionable health insights tailored to individual users.
Through this agreement, the two companies plan to offer precision health management services, including optimized weight management, sleep tracking, nutritional and dietary recommendations, and exercise regimens customized to genetic predispositions. Gentok’s microbiome analysis service, "the Biome," will also integrate with Samsung Health. This will provide detailed insights into the balance of gut microbiota affecting weight, metabolism, and even mental health conditions such as depression, enabling a wide range of lifestyle management guidance.
Gentok is a digital healthcare platform offering genetic and microbiome-d health management solutions. It provides insights across 129 genetic testing items, including obesity, hair loss, nutrition, dietary habits, exercise, sleep patterns, and skin traits, making it the most comprehensive service of its kind in Korea.
Samsung Health, Samsung Electronics’ global health platform, helps users monitor key health metrics such as sleep, exercise, and diet while fostering a holistic understanding of their health for continuous improvement.
Changhoon Kim, CEO of Macrogen, said, "This supply agreement marks a pivotal step in bringing personalized, integrated health solutions into users’ daily lives by connecting Gentok genetic testing data with the Samsung Health app’s lifestyle logs. Macrogen is committed to advancing technological leadership in futuristic fields like healthcare and genetic analysis. By refining data-driven services and creating new markets, we aim to revolutionize digital healthcare for the super-aging and personalization era, ushering in a transformative shift in health management."